Company Filing History:
1 out of 5 
1 out of 832,880 Years Active: 1998-2006
Title: Alicia Ines Bravo: Innovator in Tumor Therapy
Introduction
Alicia Ines Bravo is a prominent inventor based in Buenos Aires, Argentina. She has made significant contributions to the field of cancer research, particularly in developing therapies aimed at tumor treatment. With a total of 2 patents, her work focuses on innovative methods to combat cancer cells.
Latest Patents
Alicia's latest patents include groundbreaking inventions such as "Compositions and methods for tumour therapy." This patent describes compositions and methods that decrease or inhibit osteonectin activity in tumor cells, including cancer cells. The result is that the cells cease to be tumor-like or become less tumor-like. Additionally, she has developed a patent titled "Monoclonal antibodies reactive with tumor proliferating cells." This invention concerns monoclonal antibodies directed against breast carcinoma cells. It involves producing immunoglobulin-secreting hybridoma cultures using undifferentiated breast cancer cells as antigens for immunization. The selected hybridomas secrete antibodies that are highly reactive with tumor proliferating cells, which have particular applications in aiding the diagnosis or treatment of cancer.
Career Highlights
Throughout her career, Alicia has worked with notable institutions, including the Fundación Instituto Leloir. Her research has significantly advanced the understanding and treatment of cancer, showcasing her dedication to improving patient outcomes.
Collaborations
Alicia has collaborated with esteemed colleagues such as Jose Mordoh and Silvia Leis De Cerone. These partnerships have further enriched her research and contributed to her innovative work in the field.
Conclusion
Alicia Ines Bravo stands out as a key figure in cancer research, with her innovative patents paving the way for new therapeutic approaches. Her contributions continue to inspire advancements in the fight against cancer.